These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8969734)

  • 1. Effect of methylene blue on refractory neonatal hypotension.
    Driscoll W; Thurin S; Carrion V; Steinhorn RH; Morin FC
    J Pediatr; 1996 Dec; 129(6):904-8. PubMed ID: 8969734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
    Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
    Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume?
    Donati A; Conti G; Loggi S; Münch C; Coltrinari R; Pelaia P; Pietropaoli P; Preiser JC
    Crit Care Med; 2002 Oct; 30(10):2271-7. PubMed ID: 12394955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue reverses endotoxin-induced hypotension.
    Keaney JF; Puyana JC; Francis S; Loscalzo JF; Stamler JS; Loscalzo J
    Circ Res; 1994 Jun; 74(6):1121-5. PubMed ID: 8187278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue.
    Weingartner R; Oliveira E; Oliveira ES; Sant'Anna UL; Oliveira RP; Azambuja LA; Friedman G
    Braz J Med Biol Res; 1999 Dec; 32(12):1505-13. PubMed ID: 10585632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene blue administration in septic shock: a clinical trial.
    Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
    Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study.
    Kirov MY; Evgenov OV; Evgenov NV; Egorina EM; Sovershaev MA; Sveinbjørnsson B; Nedashkovsky EV; Bjertnaes LJ
    Crit Care Med; 2001 Oct; 29(10):1860-7. PubMed ID: 11588440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged methylene blue infusion in refractory septic shock: a case report.
    Dumbarton TC; Minor S; Yeung CK; Green R
    Can J Anaesth; 2011 Apr; 58(4):401-5. PubMed ID: 21246318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene blue increases myocardial function in septic shock.
    Daemen-Gubbels CR; Groeneveld PH; Groeneveld AB; van Kamp GJ; Bronsveld W; Thijs LG
    Crit Care Med; 1995 Aug; 23(8):1363-70. PubMed ID: 7634806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of methylene blue in septic shock: pros and cons.
    Arias-Ortiz J; Vincent JL
    Crit Care; 2024 Feb; 28(1):46. PubMed ID: 38365828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene Blue for Refractory Shock in Polytraumatized Patient: A Case Report.
    Volpon LC; Evora PRB; Teixeira GD; Godinho M; Scarpelini S; Carmona F; Carlotti APCP
    J Emerg Med; 2018 Oct; 55(4):553-558. PubMed ID: 30122524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock.
    Juffermans NP; Vervloet MG; Daemen-Gubbels CR; Binnekade JM; de Jong M; Groeneveld AB
    Nitric Oxide; 2010 May; 22(4):275-80. PubMed ID: 20109575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats.
    Wu CC; Chen SJ; Yen MH
    Am J Physiol; 1998 Oct; 275(4):H1148-57. PubMed ID: 9746461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene blue versus vasopressin analog for refractory septic shock in the preterm neonate: A randomized controlled trial.
    Ismail R; Awad H; Allam R; Youssef O; Ibrahim M; Shehata B
    J Neonatal Perinatal Med; 2022; 15(2):265-273. PubMed ID: 34719443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene Blue Administration for Distributive Shock States in Critically Ill Children.
    Bitterman Y; Hubara E; Hadash A; Ben-Ari J; Annich G; Eytan D
    Isr Med Assoc J; 2020 Jul; 22(7):404-408. PubMed ID: 33236563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Use of Methylene Blue in the Pediatric ICU.
    Rutledge C; Brown B; Benner K; Prabhakaran P; Hayes L
    Pediatrics; 2015 Oct; 136(4):e1030-4. PubMed ID: 26347436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of methylene blue in sepsis: a systematic review.
    Kwok ES; Howes D
    J Intensive Care Med; 2006; 21(6):359-63. PubMed ID: 17095500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.
    Mount JC; Rowe AS
    Pharmacotherapy; 2010 Mar; 30(3):323. PubMed ID: 20180614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome.
    Samlowski WE; Kondapaneni M; Tharkar S; McGregor JR; Laubach VE; Salvemini D
    J Immunother; 2011 Jun; 34(5):419-27. PubMed ID: 21577143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.